71818-74-1

Usage

Uses

Used in Pharmaceutical Industry:
Acetamide, N-[4-(cyano-4-morpholinylmethyl)phenyl]is used as a potential anti-cancer agent for its ability to inhibit the growth of cancer cells. Its application in this field is based on the observed effects in laboratory studies, which suggest it could be a valuable component in the development of new cancer treatments.
Used in Medical Research:
In the context of medical research, Acetamide, N-[4-(cyano-4-morpholinylmethyl)phenyl]is utilized for its potential as an anti-inflammatory and analgesic agent. Acetamide, N-[4-(cyano-4-morpholinylmethyl)phenyl]-'s properties are being investigated to understand its full therapeutic potential, which could lead to the development of new medications for pain relief and inflammation management.
Further research is essential to determine the safety, efficacy, and optimal applications of Acetamide, N-[4-(cyano-4-morpholinylmethyl)phenyl]in various fields, including its possible use in drug delivery systems or other therapeutic approaches.

Upstream product

• 110-91-8 morpholine 
• 151-50-8 potassium cyanide 
• 122-85-0 para-acetamidobenzaldehyde 

Downstream Products

• 184766-81-2 4-Chloro-2-(3-{1,1-dimethyl-2-[4-(4-methyl-6-oxo-1,4,5,6-tetrahydro-pyridazin-3-yl)-phenylamino]-ethylamino}-2-hydroxy-propoxy)-5-(tetrahydro-pyran-2-yloxy)-benzonitrile 
• 114872-19-4 6-[4-(2-amino-2-methylpropylamino)phenyl]-5-methyl-4,5-dihydro-3(2H)-pyridazinone 

Relevant academic research and scientific papers

Studies on agents with vasodilator and β-blocking activities. IV

A series of novel pyridazinone derivatives (II) having a phenoxypropanolamine moiety was synthesized. Their hypotensive and β- blocking activities were evaluated after intravenous administration of the compounds to anesthetized rats. Among them, the 5-chloro-2-cyanophenoxy derivative (29) showed the promising dual activities and was selected for further studies.